stocktrader

Intel stock hits new street-high target: is it too late to buy INTC?

Intel stock’s (NASDAQ: INTC) turnaround story got louder in recent days, but so did the valuation debate around it. The chipmaker is under the spotlight after first-quarter 2026 revenue of $13.58 billion and non-GAAP earnings of 29 cents a share, both ahead of expectations. Intel guided second-quarter revenue to $13.8 billion to $14.8 billion and… Continue reading Intel stock hits new street-high target: is it too late to buy INTC?

DeepSeek price slash fuels competition, hits Zhipu, Minimax

Chinese artificial intelligence startup DeepSeek has introduced a preview of its fourth-generation model, DeepSeek V4, alongside sweeping price cuts aimed at accelerating adoption. The company said it is offering developers a 75% discount on its newly unveiled AI model, DeepSeek-V4-Pro, until May 5. It also reduced prices for input cache hits across its entire API… Continue reading DeepSeek price slash fuels competition, hits Zhipu, Minimax

Has Wall St been bailed out so many times it can no longer price a crisis?

The United States is two months into its most consequential military operation since Iraq. Oil prices have surged more than 55%, and the IMF has cut its global growth forecast. At the same time, the S&P 500 just closed above 7,000 for the first time in history. US market indices are surging. This contradiction explains… Continue reading Has Wall St been bailed out so many times it can no longer price a crisis?

Why is Sun Pharma betting $11.75B on a struggling US drugmaker?

In one of the biggest outbound acquisitions ever attempted by an Indian company, Sun Pharmaceutical Industries has decided to buy Organon & Co. for $14 a share in an all-cash deal valued at $11.8 billion. The logic of the deal is easy to state and harder to execute as Sun is not buying a fast-growing… Continue reading Why is Sun Pharma betting $11.75B on a struggling US drugmaker?

Hang Seng slips as Asian markets split; Nikkei, Kospi hit new highs

Asia began the week with a split-screen session, as Tokyo and Seoul extended their record run, while Australia and Hong Kong lagged behind. The Nikkei 225 and South Korea’s Kospi opened at fresh highs, reflecting continued appetite for markets with strong earnings momentum and clear technology-led narratives. Australia’s ASX 200 slipped in holiday-thinned trade and… Continue reading Hang Seng slips as Asian markets split; Nikkei, Kospi hit new highs

Brent crude oil price analysis as contentious US-Iran ceasefire continues

Crude oil price continued rising on Monday as investors reacted to the new developments on the US-Iran war. Brent, the global benchmark, soared to a high of $107, much higher than the year-to-date low of $55. The West Texas Intermediate (WTI) continued soaring as well and crossed $100. US-Iran ceasefire continues as war risks rise… Continue reading Brent crude oil price analysis as contentious US-Iran ceasefire continues

USD/JPY forecast: triangle forms ahead of FOMC, BoJ rate decisions

The USD/JPY exchange rate will be in the spotlight this week as the Federal Reserve and the Bank of Japan (BoJ) publish their interest rate decisions. It was trading slightly below the important resistance level at 160 as traders wait for these events and as the Iran crisis continued. BoJ interest rate decision The USD… Continue reading USD/JPY forecast: triangle forms ahead of FOMC, BoJ rate decisions

Meta, Microsoft earnings due next week: here’s what top analysts say

Meta Platforms and Microsoft will give Wall Street its most important AI test of the quarter on Wednesday, April 29, when both companies report after the bell. Meta’s Q1 2026 earnings call is set for 2:30 p.m. PT, while Microsoft has said it will publish fiscal Q3 2026 results after the close of the same… Continue reading Meta, Microsoft earnings due next week: here’s what top analysts say